Tampa, FL – August 24, 2005 – Pilgrim Software, Inc., the leading provider of Enterprise Compliance and Quality Management Solutions, announces that Genzyme Corporation has purchased additional users for their SmartCAPA solution.

To provide a common platform for managing deviations, resulting CAPA activities and to standardize global CAPA processes, Genzyme purchased SmartCAPA in 2003. The pilot for their Bio-Surgery and TMD divisions has been completed. The additional users will allow for the expansion for continuing global process management.

SmartCAPA is designed specifically to address the corrective action/preventive action, non-conformance processes and products, customer complaints and product return of an entire organization from the administrative office to the product floor. It manages the complete cycle off action from the detection phase to the final resolution of the issue.

“The SmartCAPA implementation at our 2 sites has been successful. With the additional users purchased, we will begin the expansion to our other sites. SmartCAPA has proven itself to be an excellent tool for initiating and resolving corrective and preventive actions. To identify root causes and prevent recurrence of the original action has been cost-effective. We’re also confident in our compliance with all the FDA requirements,” states Ben Greene, Sr. VP of Quality Assurance.

“We are always pleased when our customers expand the usage of our solution,” states Ami Utji, President and CEO of Pilgrim Software. “This affirms that customers such as Genzyme realize the benefits of a single tool that provides a solid common platform for globally managing deviations and resulting CAPA activities.”


About Genzyme Corporation
One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Founded in 1981, Genzyme has grown from a small start-up to a diversified enterprise with 2005 revenues expected to exceed $2.6 billion and more than 7,600 employees in locations spanning the globe. With many established products and services helping patients in more than 80 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant and immune diseases, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields as well as heart disease and other areas of unmet medical need. For more information about Genzyme, visit their website at www.genzyme.com. 


About Pilgrim Software, Inc.  
Pilgrim Software, Inc. is the leading provider of Enterprise Compliance and Quality Management solutions for global organizations and is one of only 12 strategic Microsoft Independent Software Vendors (ISV) within the manufacturing vertical. Pilgrim helps organizations manage industry and regulatory compliance, reduce manufacturing costs and improve customer satisfaction. By providing live connections to multiple sites, suppliers and customers, Pilgrim enables organizations to centrally manage all of their worldwide compliance efforts and quality operations – providing real-time visibility tied to fast action. The results are a lean, performance-driven enterprise that can respond to change with speed and power. For more information, visit Pilgrim Software’s Web site at www.pilgrimsoftware.com.